Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 933 results for "glenmark"

Glenmark to set up first manufacturing facility in US

Glenmark Pharmaceuticals To Build its First Facility in the US

Mumbai India-based Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company, plans to set up a new manufacturing facility in the U.S. The facility will be situated in Monroe, North Carolina, at the Monroe Corporate ... CoStar Group, 21 hours ago
Glenmark Pharma to build new manufacturing plant in US Pharmaceutical Business Review, 4 days ago

107 images for glenmark, 1 day ago
Pharma Letter, 7 hours ago, 1 day ago
Bio Spectrum Asia, 1 week ago
NDTV, 1 week ago
European Pharmaceutical Manufacturer, 1 week ago
Sify, 13 hours ago, 1 week ago
NDTV, 1 day ago
NDTV Profit, 1 day ago
Pharma Letter

Glenmark reports strong growth everywhere but the USA

India-based generics manufacturer Glenmark has seen its consolidated revenue increase by more than 20% in the quarter ending June 2014 to 14,869 million rupees ($248 million). Consolidated earnings before interest, taxes, depreciation and ...
 Pharma Letter7 hours ago Glenmark's consolidated revenue increases by 20.08 % to Rs. 14,869.40 Mn for Q1 - FY 14 15  FirstWord Pharma1 day ago Glenmark Advances Antibody Into Phase I In Autoimmune Diseases  Bioresearch Online2 weeks ago Glenmark's Novel Monoclonal Antibody GBR 830 for Treatment of Autoimmune Diseases Entering Human Trials  PipelineReview2 weeks ago

Pharma shares in demand; Healthcare index hits new high

Sun Pharma, Ranbaxy, Dr Reddy's Lab, Lupin, Glenmark, Wockhardt and Cadila Healtchare gained 1-8% on BSE.
 Business Standard11 hours ago Healthcare and pharma: Fear of pricing action  Financial Express3 weeks ago Lupin, Dr Reddys Lab top picks in pharma space: ICICIdirect  Money Control2 weeks ago

Glenmark surges 6%; Macquarie maintains outperform post Q1

Macquarie maintains outperform with a target of Rs 835 per share. The brokerage expects emerging markets strong growth momentum to continue and is hoping the US markets to pick up in second half, which was subdued due to lack of approvals in Q1FY15.
 Money Control11 hours ago
Money Control

Stocks in news: Wipro, SKS, Ambuja, Ranbaxy, JSW Energy

Biocon | Bharti Infratel | SKS Microfinance | Ambuja Cements | Ranbaxy Labs | PNB | Ashok Leyland | Glenmark Pharma | Ambuja Cements | Mirc Electronics | PI Industries | Rajshree Sugars | Indiabulls Housing Finance | Birla Precision Technologies | TVS Motor | ...
 Money Control17 hours ago Stocks in news: Wipro, TVS Motor, Cairn, Concor, LT Fin  Moneycontrol.com1 day ago Top 10 stocks to focus on June 30  Money Control3 weeks ago Top10 stocks to watch out for in trade today  Money Control2 months ago

Glenmark continues to struggle in US

Glenmark Pharmaceutical's 20 per cent sales growth in the June quarter suggests the company lacks any major growth trigger in FY15. Sales growth in the first quarter has been marred by anaemic growth in the US, as no new products have been launched. While ...
 Sify13 hours ago Glenmark faces up to slower US growth  Livemint.com1 day ago Pharma cos to show 24% sales growth in Q1FY15: BoA-ML  MyIris3 weeks ago

Dr Reddy's, Glenmark, Ranbaxy to get astro support: Gupta

According to Satish Gupta of, pharma stocks like Dr Reddy's Laboratories, Glenmark Pharma, Shasun Pharmaceuticals and Ranbaxy Laboratories will be getting astrological support.
 Money Control14 hours ago Lupin, Wockhardt, Glenmark to get astro support: Gupta  Money Control2 months ago

Glenmark Pharma surges after strong Q1 results

Glenmark Pharmaceuticals surged 5.32% to Rs 628 at 9:46 IST on BSE after consolidated net profit jumped 43.65% to Rs 184.84 crore on 20.08% growth in revenue to Rs 1486.94 crore in Q1 June 2014 over Q1 June 2013. The Q1 result was announced ...
 Capital Market16 hours ago Glenmark Pharma stock surges 6%  India Infoline13 hours ago Glenmark Pharma surges on strong June quarter results  Business Standard14 hours ago

Glenmark retains FY15 sales target; to launch 8 pdts in US

The company told analysts that it has received USD 5 million from Sanofi as licensing fee. It said its clinical trials for GBR 900 were progressing well.
 Money Control16 hours ago

Glenmark continues to struggle in US

Related to : Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals Ltd BSE 24 Jul 14 | 12:00 AM 596.25 4.6 (0.78%) NSE 24 Jul 14 | 12:00 AM 596.85 4.95 (0.84%) Glenmark Pharmaceutical's 20 per cent sales growth in the June ...
 Smart Investor17 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less